Differential Tear Lipid Metabolomics Signatures Discriminate Superior Limbic Keratoconjunctivitis From Dry Eye Disease
Translational Vision Science & Technology · 2025
DOI: 10.1167/tvst.14.11.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Yan Zong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangdong Provincial Clinical Research Center for Ocular …. Hauptthemen laut MEDLINE: Tears, Metabolomics, Dry Eye Syndromes, Keratoconjunctivitis. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Superior limbic keratoconjunctivitis (SLK) and dry eye disease (DED) exhibit similar clinical manifestations, complicating diagnosis. We aimed to compare tear metabolomic profiles and secretory phospholipase A2 (sPLA2) levels in patients with SLK versus patients with DED.
Methods
We established a cross-sectional study involving 56 subjects: 20 patients with SLK, 21 patients with DED, and 15 matched healthy controls (solely for measuring sPLA2). Tear fluids collected via Schirmer strips underwent liquid chromatography with tandem mass spectrometry metabolomic analysis. Metabolites were quantitatively analyzed and matched to metabolic pathways and biomarkers. Metabolic differences between patients with SLK and patients with DED were identified through multivariate statistical analysis. Western blot measured the content of sPLA2 in tears of the three groups.
Results
Tear analysis annotated 274 metabolites. Twenty-three metabolites showed significant differences (P < 0.05) between the 2 groups, comprising 20 increased and 3 decreased in SLK. Top differential metabolic pathways were glycerophospholipid, alpha-linolenic acid, and linoleic acid metabolism. Receiver operating characteristic (ROC) analysis showed that five metabolites could be considered as potential biomarkers for distinguishing SLK from DED. Tears PLA2 was significantly higher in SLK than healthy controls (p < 0.05), but without difference between SLK and DED.
Conclusions
The study revealed distinct metabolomic profiles in SLK versus DED tears, with notable changes in glycerophospholipid metabolism and elevated sPLA2 levels in SLK. Translational Relevance: Tear metabolomics distinguishes SLK from DED at the molecular level through dysregulated glycerophospholipid metabolism. In SLK, compared with controls, this dysregulation coincides with elevated sPLA2, an enzyme hydrolyzing glycerophospholipids, indicating lipid-driven inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, People's Republic of China.
- Department of Ophthalmology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, People's Republic of China.
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Zitieren
APA
Zong, Y., Liu, S., Yu, Y., Wang, C., Cheng, C., Liu, X., Du, J., Gu, Y., & Wu, K. (2025). Differential Tear Lipid Metabolomics Signatures Discriminate Superior Limbic Keratoconjunctivitis From Dry Eye Disease. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.11.37
Vancouver
Zong Y, Liu S, Yu Y, Wang C, Cheng C, Liu X, et al. Differential Tear Lipid Metabolomics Signatures Discriminate Superior Limbic Keratoconjunctivitis From Dry Eye Disease. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.11.37
BibTeX
@article{Zong2025,
author = {Zong, Yan and Liu, Sihao and Yu, Yubin and Wang, Chunxiao and Cheng, Chao and Liu, Xiuping and Du, Jiangbo and Gu, Yonghui and Wu, Kaili},
title = {Differential Tear Lipid Metabolomics Signatures Discriminate Superior Limbic Keratoconjunctivitis From Dry Eye Disease},
journal = {Translational Vision Science & Technology},
year = {2025},
doi = {10.1167/tvst.14.11.37}
}
EUVIMED